Back to search

Article

Screening of FDA-approved small molecules to discover inhibitors of the <i>Pseudomonas aeruginosa</i> quorum-sensing enzyme, PqsE

2025-07-25

Abstract excerpt

Pseudomonas aeruginosa is a notorious pathogen that is a leading cause of hospital-acquired infections. Due to its heightened resistance to a broad range of antibiotics, there is great need for new antimicrobial agents that are effective in treating P. aeruginosa infections. One attractive option for exploring new antibiotic targets is the quorum sensing (QS) pathway, as it governs many of the pathogenic behavior...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
067eac86-d34e-5b8d-9576-8efd78785230
DOI
10.1101/2025.07.25.666791
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Screening of FDA-approved small molecules to discover inhibitors of the <i>Pseudomonas aeruginosa</i> quorum-sensing enzyme, PqsEDOI 10.1101/2025.07.25.666791
Select a neighboring publication to make it the new centre.